Earth Science Tech ETST

OTC ETST
$0.11 +0.02 (+29.41%)
At close: Aug 19, 2026 · 2:39 PM UTC
Financial Ratios
Market Cap24.65 Mn
P/E6.39
P/S0.69
Div. Yield0.00
ROIC (Qtr)0.50
Revenue Growth (1y) (Qtr)3.03
Add ratio to table…

About

Earth Science Tech, Inc. operates as a strategic holding company focused on value creation through the acquisition, operational optimization, and management of its operating businesses. The company leverages a diversified portfolio of subsidiaries to create synergies across pharmacy, telemedicine, real estate, healthcare services, and consumer products. Earth Science Tech, Inc. generates revenue primarily from product sales of compounded medications through its RxCompound…

Read more ↓
Sector: Healthcare Sector rationale The company's primary revenue drivers are its compounding pharmacies (RxCompound and Mister Meds), telemedicine referral platform (Peaks Curative), and healthcare facility services (Las Villas Health Care). A secondary sector of Real Estate is justified because the company operates Avenvi, a substantial business line dedicated to real estate development, asset management, and financing. Industries: +2 more Generic Drugs Healthcare Primary The company generates primary revenue from the sale of compounded medications through its RxCompound and Mister Meds pharmacies, which are licensed compounding pharmacies. Telehealth Healthcare Secondary The company operates Peaks Curative, a telemedicine referral platform that offers asynchronous consultations for patients seeking compounded medications. Healthcare Services Healthcare Secondary The company operates Las Villas Health Care, a brick-and-mortar healthcare facility providing specialized sexual health treatments and physical performance solutions. Classified using BQ-MICS CIK: 0001538495

Product and Service Breakdown of Revenue (2026)

Peer Comparison

Companies in the Drug Manufacturers - Specialty & Generic
S.No. Ticker Company Market CapP/EP/STotal Debt (Qtr)
1 HLN Haleon plc 86.50 Bn80.681.67-5.81 Bn
2 TEVA Teva Pharmaceutical Industries Ltd 42.71 Bn61.362.4716.59 Bn
3 ZTS Zoetis Inc. 30.86 Bn11.803.249.05 Bn
4 TAK Takeda Pharmaceutical Co Ltd 28.50 Bn49.630.6131.47 Bn
5 UTHR UNITED THERAPEUTICS Corp 22.06 Bn16.836.99-
6 VTRS Viatris Inc 18.84 Bn-45.871.2813.35 Bn
7 NBIX Neurocrine Biosciences Inc 15.55 Bn22.034.61-
8 VREOF Vireo Growth Inc. 11.86 Bn-238.0033.850.20 Bn